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Summary We hypothesized a suppressive mechanism for docosahexaenoic acid (22:6n-3;
DHA)-induced tissue lipid peroxidation in which the degradation products, especially aldehydic
compounds, are conjugated with glutathione through catalysis by glutathione S-transferases,
and then excreted into urine as mercapturic acids. In the present study, ascorbic acid-requir-
ing ODS rats were fed a diet containing DHA (3.6% of total energy) for 31 days. Lipid per-
oxides including degradation products and their scavengers in the liver and kidney were
determined, and the temporal change in the urinary excretion of mercapturic acids was also
measured. The activity of aldehyde dehydrogenase, which catalyzes the oxidation and detoxi-
fication of aldehydes, tended to be higher in the liver of DHA-fed rats. The levels of lipid per-
oxides as measured by thiobarbituric acid-reactive substances and aldehydic compounds were
higher and that of α-tocopherol was lower in the liver, and the pattern of temporal changes
in the urinary excretion of mercapturic acids was also different between the n-6 linoleic acid
and DHA-fed rats. Accordingly, we presume from these results that after dietary DHA-
induced lipid peroxidation, a proportion of the lipid peroxidation-derived aldehydic degrada-
tion products is excreted into urine as mercapturic acids.
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Introduction
Docosahexaenoic acid (22:6n-3; DHA) together with
eicosapentaenoic acid (20:5n-3; EPA) is the predominant n-3
polyunsaturated fatty acid (PUFA) in fish oils. Consumption
of fish oils is particularly associated with a low incidence
of atherosclerosis and cardiovascular diseases, and this
prophylactic effect is attributed to n-3 PUFAs, such as EPA
and DHA [1–7]. In recent years, de Urquiza et al. [8] have
reported that DHA may influence neural function through
activation of a retinoid X receptor signaling pathway in
brain tissue.
However, DHA is very prone to lipid peroxidation
because of its unstable chemical structure with six double
bonds. It was reported that the relative reaction rate constant
of peroxidation was 1, 2, 3, 4 and 5 against unsaturated fatty
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acids in which the number of methylene group among
double bonds was 1, 2, 3, 4 and 5, respectively [9]. In
previous studies, we and other groups showed that DHA
ingestion [10–16], similar to fish oil ingestion [17–21],
enhanced the susceptibility of rat liver and kidney to lipid
peroxidation and increased the requirement for vitamin E
(Vit. E). The enhancement was a function of dietary DHA
levels [22–24] and was thought to be attributable to the
substitution of membrane fatty acids with highly unsaturated
DHA, as similarly suggested by Vaagenes et al. [11].
However, we found that DHA ingestion did not increase
the end products of lipid peroxidation, such as lipofuscin, in
the liver of rats fed a physiological requirement level of Vit.
E [13, 15, 16]. We hypothesize that there are primarily two
suppressive mechanisms for it. One is an antioxidative
mechanism that suppresses the generation of lipid peroxides,
and the other is detoxification and/or excretion mechanisms
that suppress the accumulation of lipid peroxides and their
degradation products, particularly reactive aldehydes. The
former mechanism is thought to be exerted through
increases in ascorbic acid (AsA) and glutathione (GSH)
induced by DHA intake [13,  14,  23], which potentiates
reductive recycling of Vit. E, thus maintaining antioxidative
potency. However, the DHA-induced generation of tissue
lipid peroxides was not suppressed further even after higher
doses of Vit. E [12, 13], or after higher doses of AsA and
methionine [15, 16]. Methionine is necessary for the synthesis
of GSH via cysteine. Accordingly, the antioxidative potency
exerted through Vit. E, AsA and GSH is not enough to
suppress the generation of lipid peroxides. Additionally,
ingestion of DHA did not increase liver glutathione reductase
and glutathione peroxidase activities, even though the tissue
lipid peroxide levels in DHA-fed rats were higher [13, 14].
These observations suggest that some mechanisms other
than antioxidants and antioxidant enzymes are induced after
DHA ingestion in order to suppress the accumulation of
lipid peroxides and their degradation products leading to end
products of lipid peroxidation.
When 4-hydroxy-2-hexenal (4-HHE) [25] and 4-hydroxy-
2-nonenal (4-HNE) [26] as secondary n-3- and n-6-
PUFA derived degradation products of lipid peroxidation,
respectively, were injected directly into the blood stream of
rats, the mercapturic acids (acetylcysteine conjugates) derived
metabolically from conjugates of the aldehydes with GSH
were detected in the urine. Therefore, we presume that
detoxification and/or excretion of reactive aldehydes derived
from dietary DHA-induced lipid peroxidation is a second
mechanism for suppressing the gradual accumulation of lipid
peroxides and their degradation products, in which glutathione
S-transferases (GSTs) firstly catalyze the conjugation of
lipid peroxidation-derived aldehydes with GSH. In addition,
we hypothesize that another mechanism involving dietary
DHA-induced biotransformation mediated by aldehyde
dehydrogenase (ALDH) detoxifies reactive aldehydes,
resulting in formation of their carboxylic acids [26].
In this study, therefore, we focused in particular on
detoxification and/or excretion mechanisms for suppressing
the accumulation of lipid peroxides and their degradation
products induced after DHA intake. Our previous study
showed that DHA ingestion elevated the urinary excretion of
mercapturic acids on day 28 in Sprague-Dawley rats [27].
Hence, we measured here the temporal change in the urinary
excretion of mercapturic acids in AsA-requiring Osteogenic
Disorder Shionogi/Shi-od/od (ODS) rats after DHA intake.
We used this specific rat strain to restrict the effects of an
antioxidant AsA as least as possible because our previous
studies showed that AsA was increased in tissues by DHA
ingestion [13, 14, 23]. Clarification of the mechanisms that
suppress dietary DHA-induced lipid peroxidation is important
not only for reasons of safety, but also to formulate a means
of efficiently enhancing the physiological effectiveness of n-
3 PUFAs.
Materials and Methods
Animals and diets
The experimental procedures used in this study met the
guidelines of the animal handling committee in Incorporated
Administrative Agency, National Institute of Health and
Nutrition (Tokyo, Japan).
Male AsA-requiring ODS rats (CLEA Japan, Tokyo,
Japan), lacking l-gulono-γ-lactone oxidase in the AsA
biosynthetic pathway [28], 6 weeks of age and weighing
120–140 g, were housed individually in stainless-steel wire-
bottomed cages kept at a constant temperature of 22 ± 1°C
and humidity of 50–60% with a 12 h light-dark cycle. The
composition of the experimental diets, based on the AIN-76
purified diet for rats [29,  30], is shown in Table 1. For
experimental groups, six rats each were assigned to two
groups: LA and DHA groups. The diets were fed for 31
days. The dietary lipid level was 70 g/kg diet. In the LA diet,
the level of linoleic acid (18:2n-6; LA) was 6.3% of total
energy. In the DHA-containing diet, the level of LA and
DHA were 2.0 and 3.6% of total energy, respectively. For
energy calculation, Atwater energy factors [31] were used.
The proportion of total PUFA was at almost the same level
in the LA- and DHA-containing diets. The Vit. E content as
RRR-α-tocopherol equivalent, which is calculated by the
biopotency ratio of tocopherols [32], was 100 mg/kg diet.
The dietary AsA level was set at 300 mg/kg diet according
to our previous results [15]. During the experimental period,
each diet was made available to the rats in the evening and
was removed the next morning. After being deprived of food
overnight, the rats were sacrificed by cardiac puncture. The
liver and kidney were promptly excised, and the liver was
then perfused with ice-cold isotonic saline via the portalS. Sekine et al.
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vein. The liver and kidney samples were stored at −80°C until
used for the analysis.
Lipid peroxides, α-tocopherol and antioxidant enzymes
The tissue thiobarbituric acid-reactive substances (TBARS)
were measured according to the method of Ohkawa et al. [33]
with a minor modification, in which butylated hydroxytoluene
was added to the reaction mixture at a final concentration
of 0.45 mM. TBARS are expressed in terms of the malon-
dialdehyde (MDA) equivalent. The MDA + 4-hydroxy-2-
alkenals (4-HAE) in their free form in tissues were
determined using commercial BIOXYTECH®LPO-586TM
(OXIS International Inc., Foster City, CA) assay kit. The
LPO-586 method is designed to assay MDA in conjunction
with 4-HAE in methanesulfonic acid.
α-Tocopherol concentrations in the test lipids and tissues
were analyzed by HPLC [34].
Activities of GST and ALDH were determined by the
method of Jennson et al. [35] and Pietruszko and Yonetani
[36], respectively. The protein content was measured by the
method of Lowry et al. [37].
Urinary mercapturic acid excretion
To determine a temporal change in the urinary excretion
of mercapturic acids, whole urine was collected on days 0, 7,
14, 21, and 28, respectively. The urinary mercapturic acid
was analyzed by HPLC after the extraction by the method of
Kress and Pentz [38].
Fatty acid composition
Total lipids in the liver and kidney were extracted
according to the method of Bligh and Dyer [39]. Fatty acid
methyl esters of dietary lipids and total tissue lipids were
prepared and analyzed by GLC according to a previous
study [15].
Statistical analysis
Significant difference between the mean values of the LA
and DHA groups was evaluated by Student’s t test. Significant
difference among the mean values of urinary mercapturic
acids was evaluated by repeated-measures ANOVA. The
limit of significance was set at p<0.05.
Results
In the ODS rats, no signs of scurvy, such as hemorrhages
around the eyes and nose, appeared during the 31 days of the
experimental period. The rats consumed 17.3–18.4 g food/d
and gained 3.5–3.8 g/d over the 31 days of the experimental
period (data not shown). There were no significant differences
in food intake, body-weight gain, and liver and kidney
weights between the two groups (data not shown).
Various and complex mixtures of compounds derived from
in vivo lipid peroxidation, including TBA-reactive precursors
which degrade under the acidity and heating conditions used
in the assay, react with TBA. These degradable precursors
include lipid hydroperoxides, hydroperoxyendoperoxides and
so forth. The aldehydic degradation products from in vivo lipid
peroxidation, such as malondialdehyde, alkenals, alkadienals
and so on in their free form, also react with TBA but these
free aldehydes are produced after in vivo lipid peroxidation
has been extensively promoted.
The TBARS and free MDA + 4-HAE levels in the liver
were significantly higher with DHA intake as indicated in
Table 2. The α-tocopherol level was significantly lower with
DHA intake. The GST and ALDH activities did not differ
between the two groups although the latter activity tended to
be higher with DHA intake.
Table 1. Composition of experimental diets (g/kg diet) and fatty
acid composition (g/100 g) of dietary lipids given to
ODS rats1
Group LA DHA
% total energy
Linoleic acid 6.3 2.0
DHA — 3.6
g/kg diet
Basic components2 930 930
Test lipids3 70 70
Safflower oil 35 7
Olive oil 35 42
DHA concentrate4 —2 1
Fatty acids g/100 g
16:0 8.3 7.1
18:0 2.3 2.1
18:1 (n-9) 46.8 51.8
18:2 (n-6) LA 40.6 13.0
18:3 (n-3) 0.3 0.4
20:4 (n-6) AA ND 0.5
20:5 (n-3) EPA ND 0.4
22:5 (n-6) ND 0.2
22:5 (n-3) ND 0.5
22:6 (n-3) DHA ND 22.8
Others 1.3 1.0
PUFA 40.9 37.8
1 The vitamin E content as RRR-α-tocopherol equivalent of the
experimental diets was 100 mg/kg diet. ND, not detectable.
2 The basic components of the diet given to the groups were as
follows: casein, 200.0 g; DL-methionine, 3.0 g; cornstarch, 150.0 g;
sucrose, 239.7 g; glucose, 240.0 g; cellulose powder, 50.0 g; AIN-
76 vitamin mixture [29, 30], 10.0 g; AIN-76 mineral mixture [29],
35.0; choline bitartrate, 2 g; ascorbic acid 0.3 g.
3 Fat energy percentage is 15.7% of total energy.
4 The purity of the DHA ethyl esters was 93%.DHA-Induced Lipid Peroxidation and Urinary Mercapturic Acid Excretion
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In the kidney, the TBARS level was significantly higher
with DHA intake but the free MDA + 4-HAE level did not
differ between the two groups (Table 2). The α-tocopherol
level was significantly lower with DHA intake.
The urinary excretion of mercapturic acids did not differ
significantly between the two groups on days 0, 14 and 21
(Fig. 1), but it was significantly lower in the DHA-fed group
than in the LA group on day 7. On day 28, the difference
between the two groups was not significant but the excretion
tended to be higher with DHA intake. The temporal excretion
in the LA group fed the diet rich in n-6 LA increased rapidly
after the diet intake, was kept in a plateau from day 7 to 21,
and then decreased on day 28. While that in the DHA-fed
group gradually increased until day 21 and then decreased a
little on day 28. Repeated-measures ANOVA showed a
significant difference with the experimental term and a
significant interaction between dietary oil and experimental
term. Therefore, this result indicated that the pattern of
changes in the urinary excretion of mercapturic acids was
different between the LA- and DHA-fed groups.
The major PUFA compositions of total lipids in the liver
and kidney are shown in Table 3. In the liver, the proportions
of LA and arachidonic acid (20:4n-6; AA) were significantly
lower in the DHA group than in the LA group, while those
of EPA, 22:5n-3, and DHA were significantly higher in the
DHA group. In the kidney, the proportion of LA was
significantly higher in the DHA group than in the LA group
and that of AA was significantly lower in the DHA group.
Those of EPA, 22:5n-3, and DHA were significantly higher
in the DHA group than those of the LA group.
Discussion
In this study, we focused in particular on detoxification
and/or excretion mechanisms of lipid peroxidation-derived
reactive aldehydes as described in the introduction. To prove
these mechanisms, we fed rats a high level of DHA (3.6% of
total energy), which is actually hard to ingest everyday in
our daily life. But such a model system is in particular
necessary to highlight the in vivo response and to detect it.
The TBARS and free MDA + 4-HAE levels in the liver were
significantly higher and the Vit. E level was lower with DHA
intake (Table 2). These results mean that DHA administration
stimulated lipid peroxidation to increase TBARS and free
MDA + 4-HAE levels in this study. These free aldehydes are
produced after in vivo lipid peroxidation has been extensively
promoted and not combined with macromolecules like
Table 2. Lipid peroxides and their scavengers in the liver and
kidney of ODS rats1
Group LA DHA
Liver
TBARS (nmol/g) 62.5 ± 6.2 103.2 ± 18.5*
MDA + 4-HAE
(nmol/g)
10.5 ± 2.3 14.2 ± 2.7*
α-Tocopherol 
(nmol/g)
91.8 ± 16.2 68.3 ± 11.2*
GST 
(unit/mg protein)
1.8 ± 0.3 1.8 ± 0.3
ALDH 
(unit/mg protein)
13.1 ± 1.6 15.1 ± 1.6
Kidney
TBARS (nmol/g) 158.3 ± 7.0 166.6 ± 12.4*
MDA + 4-HAE
(nmol/g)
14.1 ± 1.5 14.6 ± 2.7
α-Tocopherol 
(nmol/g)
37.9 ± 4.0 32.8 ± 11.6*
Abbreviations: ALDH, aldehyde dehydrogenase; GST, glutathione
S-transferase; MDA + 4-HAE, malondialdehyde + 4-hydroxy-2-
alkenal; TBARS, thiobarbituric acid-reactive substances.
1 Values are mean ± SD, n =6 .
* Significant difference between the LA and DHA groups using
Student’s t test (p<0.05).
Fig. 1.  Time course of urinary excretion of mercapturic acids in
ODS rats. Values are mean ± SD, n =6 .
* Significant difference between the LA and DHA
groups using Student’s t test (p<0.05). Repeated-mea-
sures ANOVA showed a significant difference with the
experimental term and a significant interaction between
dietary oil and experimental term.S. Sekine et al.
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protein. Hence, the MDA + 4-HAE level and their increase
following DHA intake were very low compared with those
of TBARS (Table 2).
As shown in Fig. 1, repeated-measures ANOVA showed
an interaction between the LA and DHA groups. This result
indicates that the pattern of urinary excretion of mercapturic
acids was different between the two groups in the
experimental term and the excretion of mercapturic acids
might be promoted gradually after DHA was ingested. The
gradual increase of mercapturic acid excretion into urine in
the DHA-fed rats reflected that of lipid peroxidation
attended by the increases in the DHA levels in tissues. In
addition, the excretion on day 28 tended to be higher with
DHA intake. This result on day 28 was similar to our
previous report [27]. We have reported the gene expression of
dietary DHA-induced multidrug resistance-associated protein
3 in the liver [40], which could mediate the transport of
reactive aldehydes conjugated with GSH into blood stream
from the liver. Therefore, the conjugates were metabolized
to mercapturic acids in the kidney, and then excreted into
urine.
However, the total activities of GSTs in the liver on day
31 did not differ significantly with DHA intake in this
experiment (Table 2). Ålin et al. [41] and Hiratsuka et al.
[42] reported that GSTA4-4 (previously called GST 8-8),
which is present as a very minor GST protein in rat liver
(approximately 1/75 of total activity of GSTs [41]), exhibited
extremely high catalytic activity towards 4-HNE. Accordingly,
even if the total activity of GSTs does not change in rats fed
DHA, GSTs might be associated with the excretion of lipid
peroxidation-derived reactive aldehydes including 4-HNE
derived from oxidation of n-6 PUFAs and even 4-HHE
derived from oxidation of n-3 PUFAs.
Danielson et al. [43] reported that the specificity constants
(kcat./Km) of GST 8-8 (GST A4-4) with 4-HNE was higher
than that with 4-HHE. Hubatsch et al. [44] also obtained
similar results. Hence, the excretion of mercapturic acids
into urine might have been higher in the LA diet group from
the early stage of the experimental period (Fig. 1). Therefore,
the temporal change in the urinary excretion of mercapturic
acids seems to reflect the difference in substrate affinity
between 4-HNE and 4-HHE with GSH for GST. The decrease
of the excretion in the LA group on day 28 after the plateau
remains to be solved but some other detoxication mechanisms
might be induced during the plateau stage. Additional
studies are now under way to thoroughly characterize the
precise mechanisms.
Alary et al. [26] and Mitchell and Peterson [45] reported
an oxidation pathway for the formation of 4-hydroxy-2-
nonenoic acid from 4-HNE through catalysis by ALDH, and
subsequent conjugation with GSH to mercapturic acid [26]
and also to mitochondrial β-oxidation. Similarly, a reduction
pathway catalyzed by alcohol dehydrogenase was reported
for the formation of 1,4-dihydroxy-2-nonene [26, 46] from
4-HNE and subsequent conjugation with GSH to mercapturic
acids [26]. However, Hartley et al. [47] and Reichard et al.
[48] indicated that 4-HNE metabolism and detoxication in
hepatocytes from normal rat liver were primarily mediated
by GST, particularly GSTA4-4, and minor or insignificant
by both ALDH and alcohol dehydrogenase, depending on
the rat liver cell types used. In this study, the concentrations
of free MDA + 4-HAE in the liver were low compared with
those of TBARS, and also the difference of the free
MDA + 4-HAE concentrations between the two groups was
small (Table 2). Therefore, the statistical significance might
not be detected in the ALDH activity.
In any case, each mechanism described above may play a
role to some degree in the detoxication and/or excretion of
lipid peroxidation-derived reactive aldehydes in DHA-fed
rats. The details of the metabolic fate remain to be solved.
In the kidney, the TBARS level was significantly higher with
DHA intake but the free MDA + 4-HAE level did not differ
significantly between the two groups (Table 2). Considering the
PUFA composition of the kidney (Table 3), the proportions
of  n-6 PUFAs with lower degree of unsaturation were
generally higher, and that of highly unsaturated DHA was
lower, than in the liver. In addition, high retroconversion
from DHA to EPA was shown in the kidney (Table 3), as has
already been reported [15, 16, 49]. Furthermore, although
the Vit. E level in the kidney becomes lower with DHA
intake, the extent of the decrease is small compared with that
in the liver (Table 2), as similarly observed already [12–14,
Table 3. Major polyunsaturated fatty acid compositions of total
lipids in the liver and kidney of ODS rats1
Group LA DHA
g/100 g
Liver
18:2 (n-6) LA 11.9 ± 1.3 8.7 ± 0.8*
20:4 (n-6) AA 17.1 ± 1.2 5.4 ± 0.3*
20:5 (n-3) EPA ND 2.9 ± 0.5*
22:5 (n-3) 0.1 ± 0.1 1.3 ± 0.1*
22:6 (n-3) DHA 2.1 ± 0.2 18.5 ± 0.6*
Kidney
18:2 (n-6) LA 8.9 ± 0.1 11.4 ± 0.4*
20:4 (n-6) AA 28.4 ± 1.0 14.1 ± 0.4*
20:5 (n-3) EPA ND 6.7 ± 0.4*
22:5 (n-3) ND 0.5 ± 0.1*
22:6 (n-3) DHA 1.1 ± 0.1 6.8 ± 0.1*
Abbreviations: AA; arachidonic acid: DHA, docosahexaenoic acid;
EPA; eicosapentaenoic acid; LA, linoleic acid; ND, not detectable.
1 Values are means ± SD, n =6
* Significant difference between the LA and DHA groups using
Student’s t test (p<0.05).DHA-Induced Lipid Peroxidation and Urinary Mercapturic Acid Excretion
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23]. Hence, the requirement for Vit. E is low in the kidney.
Because of these characteristic profiles and the plausible
difference in antioxidant potential, the difference of the lipid
peroxide levels in the kidney might have been small between
the two groups.
Accordingly, we presume from the results observed
herein that a proportion of the lipid peroxidation-derived
aldehydic degradation products following intake of DHA
might be excreted into urine as mercapturic acids via
conjugation with GSH by GST, particularly in the liver.
Additionally, this study shows that the pattern of temporal
change in the urinary excretion of mercapturic acids was
also different between the n-3 and n-6 PUFA ingestion. Such
detoxification and/or excretion mechanisms might play an
important role in suppressing tissue damages to occur.
Acknowledgments
We gratefully acknowledge the technical assistance of
Miss Kinuyo Iwata. We thank Maruha Corporation, Japan,
for the generous gift of the DHA ethyl ester concentrate.
Abbreviations
ALDH, aldehyde dehydrogenase; AA, arachidonic acid;
AsA, ascorbic acid; DHA, docosahexaenoic acid; EPA,
eicosapentaenoic acid; GSH, glutathione; GST, glutathione
S-transferase; 4-HAE, 4-hydroxy-2-alkenals; 4-HHE, 4-
hydroxy-2-hexenal; 4-HNE, 4-hydroxy-2-nonenal; LA,
linoleic acid; MDA, malondialdehyde; ODS rat, Osteogenic
Disorder Shionogi/Shi-od/od rat; PUFA, polyunsaturated
fatty acid; TBARS, thiobarbituric acid-reactive substances;
Vit. E, vitamin E.
References
[1] Bang, H.O. and Dyerberg, J.: Plasma lipids and lipoproteins
in Greenlandic west coast Eskimos. Acta. Med. Scand., 192,
85–94, 1972.
[2] Herold, P.M. and Kinsella, J.E.: Fish oil consumption and
decreased risk of cardiovascular disease: a comparison of
findings from animal and human feeding trials. Am. J. Clin.
Nutr., 43, 566–598, 1986.
[3] Harris, W.S.: Fish oils and plasma lipid and lipoprotein
metabolism in humans: a critical review. J. Lipid Res., 30,
785–807, 1989.
[4] Simopoulos, A.P.: Omega-3 fatty acids in health and disease
and in growth and development. Am. J. Clin. Nutr., 54, 438–
463, 1991.
[5] Simopoulos, A.P.: Essential fatty acids in health and chronic
disease. Am. J. Clin. Nutr., 70, 560S–569S, 1999.
[6] Calder, P.C.: n-3 polyunsaturated fatty acids and inflammation:
from molecular biology to the clinic. Lipids, 38, 343–352,
2003.
[7] Calder, P.C.: n-3 Fatty acids and cardiovascular disease:
evidence explained and mechanisms explored. Clin. Sci.
(Lond), 107, 1–11, 2004.
[8] de Urquiza, A.M., Liu, S., Sjöberg, M., Zetterström, R.H.,
Griffiths, W., Sjövall, J., and Perlmann, T.: Docosahexaenoic
acid, a ligand for the retinoid X receptor in mouse brain.
Science, 290, 2140–2144, 2000.
[9] Cosgrove, J.P., Church, D.F., and Pryor, W.A.: The kinetics
of the autoxidation of polyunsaturated fatty acids. Lipids, 22,
299–304, 1987.
[10] Demoz, A., Asiedu, D.K., Øyvind, L., and Berge, R.K.:
Modulation of plasma and hepatic oxidative status and
changes in plasma lipid profile by n-3 (EPA and DHA), n-6
(corn oil) and a 3-thia fatty acid in rats. Biochim. Biophys.
Acta., 1199, 238–244, 1994.
[11] Vaagenes, H., Muna, Z.A., Madsen, L., and Berge, R.K.:
Low doses of eicosapentaenoic acid, docosahexaenoic acid,
and hypolipidemic eicosapentaenoic acid derivatives have no
effect on lipid peroxidation in plasma. Lipids,  33, 1131–
1137, 1998.
[12] Kubo, K., Saito, M., Tadokoro, T., and Maekawa, A.: Dietary
docosahexaenoic acid dose not promote lipid peroxidation in
rat tissue to the extent expected from peroxidizability index
of tissue total lipid. Biosci. Biotech. Biochem.,  62, 1698–
1706, 1998.
[13] Kubo, K., Saito, M., Tadokoro, T., and Maekawa, A.:
Preferential incorporation of docosahexaenoic acid into
nonphosphorus lipids and phosphatidylethanolamine protects
rats from dietary DHA-stimulated lipid peroxidation. J. Nutr.,
130, 1749–1759, 2000.
[14] Saito, M. and Kubo, K.: Relationship between tissue lipid
peroxidation and peroxidizability index after α-linolenic,
eicosapentaenoic, or docosahexaenoic acid intake in rats. Br.
J. Nutr., 89, 19–28, 2003.
[15] Sekine, S., Kubo, K., Tadokoro, T., Maekawa, A., and Saito,
M.: Dietary docosahexaenoic acid-induced production of
tissue lipid peroxides is not suppressed by higher intake of
ascorbic acid in genetically scorbutic Osteogenic Disorder
Shionogi/Shi-od/od rats. Br. J. Nutr., 90, 385–394, 2003.
[16] Sekine, S., Kubo, K., Tadokoro, T., and Saito, M.: Dietary
docosahexaenoic acid-induced generation of liver lipid
peroxides is not suppressed further by elevated levels of
glutathione in ODS rats. Nutrition, 22, 385–394, 2006.
[17] Hammer, C.T. and Wills, E.D.: The role of lipid components
of the diet in the regulation of the fatty acid composition of
the rat liver endoplasmic reticulum and lipid peroxidation.
Biochem. J., 174, 585–593, 1978.
[18] Kobatake, Y., Hirahara, F., Innami, S., and Nishide, E.:
Dietary effect of n-3 type polyunsaturated fatty acids on
serum and liver lipid levels in rats. J. Nutr. Sci. Vitaminol.,
29, 11–21, 1983.
[19] Mouri, K., Ikesue, H., Esaka, T., and Igarashi, O.: The influence
of marine oil intake upon levels of lipids, α-tocopherol and
lipid peroxidation in serum and liver of rats. J. Nutr. Sci.
Vitaminol., 30, 307–318, 1984.
[20] Hu, M.L., Frankel, E.N., Leibovitz, B.E., and Tappel, A.L.:
Effect of dietary lipids and vitamin E on in vitro lipidS. Sekine et al.
J. Clin. Biochem. Nutr.
190
peroxidation in rat liver and kidney homogenates. J. Nutr.,
119, 1574–1582, 1989.
[21] Song, J.H., Fujimoto, K., and Miyazawa, T.: Polyunsaturated
(n-3) fatty acids susceptible to peroxidation are increased in
plasma and tissue lipids of rats fed docosahexaenoic acid-
containing oils. J. Nutr., 130, 3028–3033, 2000.
[22] Saito, M., Kubo, K., and Ikegami, S.: An assessment of
docosahexaenoic acid (DHA) intake with special reference to
lipid metabolism in rats. J. Nutr. Sci. Vitaminol., 42, 195–
207, 1996.
[23] Kubo, K., Saito, M., Tadokoro, T., and Maekawa, A.: Changes
in susceptibility of tissues to lipid peroxidation after ingestion
of various levels of docosahexaenoic acid and vitamin E. Br.
J. Nutr., 78, 655–669, 1997.
[24] Saito, M. and Kubo, K.: An assessment of docosahexaenoic
acid intake from the viewpoint of safety and physiological
efficacy in matured rats. Ann. Nutr. Metab.,  46, 176–181,
2002.
[25] Winter, C.K., Segall, H.J., and Jones, A.D.: Distribution of
trans-4-hydroxy-2-hexenal and tandem mass spectrometric
detection of its urinary mercapturic acid in rat. Drug. Metab.
Dispos., 15, 608–612, 1987.
[26] Alary, J., Bravais, F., Cravedi, J.P., Debrauwer, L., Rao, D.,
and Bories, G.: Mercapturic acid conjugates as urinary end
metabolites of the lipid peroxidation product 4-hydroxy-2-
nonenal in the rat. Chem. Res. Toxicol., 8, 34–39, 1995.
[27] Sekine, S., Kubo, K., Tadokoro, T., and Saito, M.: Docosa-
hexaenoic acid-induced lipid peroxidation and urinary
excretion of mercapturic acid in rats. J. Clin. Biochem. Nutr.,
39, 40–45, 2006.
[28] Kawai, T., Nishikimi, M., Ozawa, T., and Yagi K.: A
missense mutation of L-gulono-gamma-lactone oxidase
causes the inability of scurvy-prone osteogenic disorder rats
to synthesize L-ascorbic acid. J. Biol. Chem., 267, 21973–
21976, 1992.
[29] American Institute of Nutrition. 1977. Report of the American
Institute of Nutrition ad hoc committee on standards for
nutritional studies. J. Nutr., 107, 1340–1348.
[30] American Institute of Nutrition: Second report of ad hoc
committee on standards for nutritional studies. J. Nutr., 110,
1726, 1980.
[31] Atwater, W.O.: Principles of nutrition and nutritive value of
food. U. S. Dep. Agric. Farmers’ Bull., 142, 48, 1902.
[32] Mino, M., Tamai, H., Yasuda, C., Igarashi, O., Hayashi, M.,
Hirahara, F., Katsui, G., and Kijima, S.: Biopotencies of
tocopherol analogues as determined by dialuric acid-induced
hemolysis in rats. Vitamins (Japan), 62, 241–246, 1988.
[33] Ohkawa, H., Ohnishi, N., and Yagi, K.: Assay for lipid
peroxides in animal tissues by thiobarbituric acid reaction.
Anal. Biochem., 95, 351–358, 1979.
[34] Saito, M., Nakatsugawa, K., Oh-hashi, A., Nishimuta, M.,
and Kodama, N.: Comparison of vitamin E levels in human
plasma, red blood cells, and platelets following varying
intakes of vitamin E. J. Clin. Biochem. Nutr.,  12, 59–68,
1992.
[35] Jennson, H., Ålin, P., and Mannervik, B.: Glutathione
transferase isozymes from rat liver cytosol. Methods
Enzymol., 113, 504–507, 1985.
[36] Pietruszko, R. and Yonetani, T.: Aldehyde dehydrogenases
from liver. Methods Enzymol., 71, 772–781, 1981.
[37] Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J.:
Protein measurement with the Folin phenol reagent. J. Biol.
Chem., 193, 265–275, 1951.
[38] Kress, G. and Pentz, R.: A sensitive method for the
determination of urinary mercapturic acids for use in
biological monitoring. Arch. Toxicol. Suppl., 13, 104–107,
1989.
[39] Bligh, E.G. and Dyer, W.J.: A rapid method of total lipid
extraction and purification. Can. J. Biochem. Physiol., 37,
911–917, 1959.
[40] Kubo, K., Sekine, S., and Saito, M.: Induction of multidrug
resistance-associated protein MRP3 in the liver of rats fed
with docosahexaenoic acid. Biosci. Biotechnol. Biochem., 70,
1672–1680, 2006.
[41] Ålin, P., Jensson, H., Cederlund, E., Jörnvall, H., and
Mannervik, B.: Cytosolic glutathione transferases from rat
liver: primary structure of class alpha glutathione transferase
8-8 and characterization of low-abundant class Mu
glutathione transferases. Biochem. J., 261, 531–539, 1989.
[42] Hiratsuka, A., Tobita, K., Saito, H., Sakamoto, Y., Nakano, H.,
Ogura, K., Nishiyama, T., and Watanabe, T.: (S)-Preferential
detoxification of 4-hydroxy-2(E)-nonenal enantiomers by
hepatic glutathione S-transferase isoforms in guinea-pigs and
rats. Biochem. J., 355, 237–244, 2001.
[43] Danielson, U.H., Esterbauer, H., and Mannervik, B.: Structure-
activity relationships of 4-hydroxyalkenals in the conjugation
catalysed by mammalian glutathione transferases. Biochem.
J., 247, 707–713, 1987.
[44] Hubatsch, I., Ridderström, M., and Mannervik, B.: Human
glutathione transferase A4-4: an alpha class enzyme with high
catalytic efficiency in the conjugation of 4-hydroxynonenal
and other genotoxic products of lipid peroxidation. Biochem.
J., 330, 175–179, 1998.
[45] Mitchell, D.Y. and Petersen, D.R.: The oxidation of α-β
unsaturated aldehydic products of lipid peroxidation by rat
liver aldehyde dehydrogenases. Toxicol. Appl. Pharmacol.,
87, 403–410, 1987.
[46] Esterbauer, H., Zollner, H., and Lang, J.: Metabolism of the
lipid peroxidation product 4-hydroxynonenal by isolated
hepatocytes and by liver cytosolic fractions. Biochem. J.,
228, 363–373, 1985.
[47] Hartley, D.P., Ruth, J.A., and Petersen, D.R.: The hepatocellular
metabolism of 4-hydroxynonenal by alcohol dehydrogenase,
aldehyde dehydrogenase, and glutathione S-transferase.
Arch. Biochem. Biophy., 316, 197–205, 1995.
[48] Reichard, J.F., Vasiliou, V., and Petersen, D.R.: Characterization
of 4-hydroxy-2-nonenal metabolism in stellate cell lines
derived from normal and cirrhotic rat liver. Biochim. Biophys.
Acta., 1487, 222–232, 2000.
[49] Saito, M., Ueno, M., Kubo, K., and Yamaguchi, M.: Dose-
response effect of dietary docosahexaenoic acid on fatty acid
profiles of serum and tissue lipids in rats. J. Agric. Food
Chem., 46, 184–193, 1998.